Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota

Table 1 Clinical data of patients with colorectal cancer in the two groups

Groups	Control	Treatment	χ2 value	P value
Gender			3.503	0.061
Female	29	19
Male	8	14
Age (yr)			0.479	0.489
≤ 60	16	17
> 60	21	16
Tumor location			0.243	0.622
Colon	18	18
Rectum	19	15
T stage			1.425	0.233
T1-T2	4	7
T3-T4	33	26
Lymph node			0.391	0.532
Positive	24	19
Negative	13	14
TNM stage			2.700	0.259
I	3	6
II	21	13
III	13	14
Total	37	33

TNM: Tumor-node-metastasis.

Table 2 Safety evaluation in patients with colorectal cancer in the treatment group

Observation index (patients)	Unchanged	Alleviation	Aggravation
Stomachache, Bloating (9)	7 (78%)	2 (22%)	0
Diarrhea (14)	2 (14%)	12 (86%)	0
Tenesmus (12)	5 (42%)	7 (58%)	0